Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Keyphrases
Cytotoxicity
100%
Acute Lymphoblastic Leukemia Cells
100%
MLL Rearrangement
100%
Combinability
100%
ABT-737
100%
Biological Correlates
100%
Leukemia Cells
33%
Western Blot Analysis
22%
Target Validation
11%
Clinical Trials
11%
Pediatric
11%
Preclinical Testing
11%
Dual Inhibition
11%
Cell Growth Inhibition
11%
Infant Leukemia
11%
Malignant Cells
11%
Drug Synergy
11%
B-cell Lymphoma 2 (Bcl-2)
11%
BH3 Mimetics
11%
Tyrosine Kinase Inhibitor
11%
Small Molecule Inhibitors
11%
Induced Apoptosis
11%
Effective Compounds
11%
Induced Cell Death
11%
Culture Cells
11%
IC50 Value
11%
In Vitro Study
11%
Intracellular Signaling
11%
Antineoplastic Agents
11%
Sunitinib
11%
Caspase-8
11%
Molecular Changes
11%
High Affinity
11%
MLL-rearranged Leukemia
11%
Antileukemic Agents
11%
Apoptosis-related Proteins
11%
Alamar Blue Assay
11%
Bcl-2 Expression
11%
Intracellular Targets
11%
Cytochrome c (Cyt c)
11%
Drug Combination Study
11%
Bcl-2 Signaling
11%
Modulation Analysis
11%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Leukemia Cell
100%
Drug Cytotoxicity
100%
Cell Line
50%
Western Blotting
50%
Pediatrics
25%
Clinical Trial
25%
In Vitro
25%
Signal Transduction
25%
Cell Death
25%
Combination Drug
25%
Programmed Cell Death
25%
Drug Potentiation
25%
Tyrosine-Kinase Inhibitor
25%
IC50
25%
Growth Inhibition
25%
Cell Growth
25%
Poly ADP Ribose Polymerase
25%
Intracellular Signaling
25%
Anticarcinogen
25%
Chemotherapeutic Agent
25%
Sunitinib
25%
Caspase 8
25%
Cytochrome C
25%
Resazurin Assay
25%
Apoptosis Regulatory Protein
25%
Biochemistry, Genetics and Molecular Biology
Bcl-2
100%
Drug Cytotoxicity
100%
Western Blotting
66%
Clinical Trial
33%
Tyrosine Kinase Inhibitor
33%
Signal Transduction
33%
Cell Death
33%
Cell Growth
33%
Growth Inhibition
33%
Drug Potentiation
33%
Small Molecule
33%
IC50
33%
Caspase 8
33%
Poly ADP Ribose Polymerase
33%
In Vitro Study
33%
Intracellular Signaling
33%
Sunitinib
33%
Cytochrome C
33%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lymphoblastic Leukemia
100%
Leukemia
100%
Drug Cytotoxicity
100%
Western Blot
66%
Clinical Trial
33%
Combination Drug
33%
Anticarcinogen
33%
Protein Tyrosine Kinase Inhibitor
33%
Cell Culture
33%
IC50
33%
Caspase 8
33%
Sunitinib
33%
Cytochrome C
33%
Apoptosis Regulatory Protein
33%